- Home
- TXMD vs OMH Comparison
TXMD vs OMH Comparison
Compare TXMD & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXMD | OMH |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3M | 17.6M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | TXMD | OMH |
|---|---|---|
| Price | $1.66 | $0.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 55.3K | 41.5K |
| Earning Date | 11-12-2025 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $2,796,000.00 | ★ $10,264,748.00 |
| Revenue This Year | $427.09 | $28.40 |
| Revenue Next Year | N/A | $23.07 |
| P/E Ratio | $275.53 | ★ N/A |
| Revenue Growth | 75.19 | ★ 78.86 |
| 52 Week Low | $0.70 | $0.59 |
| 52 Week High | $2.44 | $5.10 |
Technical Indicators
Market Signals| Indicator | TXMD | OMH |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 40.31 |
| Support Level | $1.64 | $0.80 |
| Resistance Level | $1.78 | $0.84 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 12.55 | 12.09 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.